CHITI, ARTURO
 Distribuzione geografica
Continente #
AS - Asia 5.257
EU - Europa 5.116
NA - Nord America 3.676
SA - Sud America 939
AF - Africa 135
OC - Oceania 39
Totale 15.162
Nazione #
US - Stati Uniti d'America 3.468
RU - Federazione Russa 3.032
SG - Singapore 2.168
CN - Cina 1.507
IT - Italia 986
BR - Brasile 780
HK - Hong Kong 602
VN - Vietnam 366
FR - Francia 230
DE - Germania 192
GB - Regno Unito 159
BD - Bangladesh 136
IN - India 117
CA - Canada 99
FI - Finlandia 99
NL - Olanda 95
MX - Messico 80
SE - Svezia 71
ES - Italia 57
AT - Austria 55
JP - Giappone 55
AR - Argentina 51
ZA - Sudafrica 43
PL - Polonia 41
AU - Australia 38
TR - Turchia 35
PK - Pakistan 32
MA - Marocco 31
IQ - Iraq 30
EC - Ecuador 27
SA - Arabia Saudita 27
LT - Lituania 21
ID - Indonesia 20
MD - Moldavia 20
UZ - Uzbekistan 20
AE - Emirati Arabi Uniti 19
CO - Colombia 19
MY - Malesia 18
EG - Egitto 16
PH - Filippine 16
VE - Venezuela 16
CL - Cile 15
PY - Paraguay 14
DZ - Algeria 13
JO - Giordania 12
TH - Thailandia 12
UA - Ucraina 12
TN - Tunisia 11
IL - Israele 9
TW - Taiwan 9
KE - Kenya 7
BE - Belgio 6
BO - Bolivia 6
PE - Perù 6
GE - Georgia 5
HR - Croazia 5
JM - Giamaica 5
UY - Uruguay 5
BG - Bulgaria 4
CR - Costa Rica 4
HN - Honduras 4
IE - Irlanda 4
KR - Corea 4
NP - Nepal 4
PT - Portogallo 4
SK - Slovacchia (Repubblica Slovacca) 4
AZ - Azerbaigian 3
CG - Congo 3
CH - Svizzera 3
KH - Cambogia 3
KZ - Kazakistan 3
LB - Libano 3
OM - Oman 3
RO - Romania 3
SY - Repubblica araba siriana 3
AL - Albania 2
BH - Bahrain 2
CY - Cipro 2
DK - Danimarca 2
DM - Dominica 2
DO - Repubblica Dominicana 2
GR - Grecia 2
IR - Iran 2
KG - Kirghizistan 2
LK - Sri Lanka 2
NI - Nicaragua 2
PR - Porto Rico 2
QA - Qatar 2
SN - Senegal 2
TT - Trinidad e Tobago 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BB - Barbados 1
BS - Bahamas 1
BY - Bielorussia 1
BZ - Belize 1
CI - Costa d'Avorio 1
CU - Cuba 1
CZ - Repubblica Ceca 1
EE - Estonia 1
Totale 15.145
Città #
Singapore 1.173
Moscow 669
Ashburn 629
San Jose 620
Hong Kong 585
Dallas 516
Shanghai 299
Milan 251
Beijing 240
Hefei 228
New York 227
Lauterbourg 192
Los Angeles 130
Ho Chi Minh City 118
Hanoi 88
Rome 81
Council Bluffs 64
São Paulo 62
Santa Clara 61
Orem 55
Nuremberg 53
Munich 52
Seattle 51
Boardman 47
Chennai 46
Tokyo 42
Montreal 40
Washington 40
Helsinki 39
Turku 39
Denver 38
Mexico City 35
Brooklyn 34
London 33
Warsaw 33
Amsterdam 32
Frankfurt am Main 30
Johannesburg 30
Atlanta 28
Naples 25
Phoenix 25
Poplar 25
Chicago 23
Stockholm 23
Belo Horizonte 22
Toronto 22
Houston 21
Bologna 20
Canberra 20
Lappeenranta 20
Rio de Janeiro 20
Guangzhou 19
Manchester 19
Valencia 19
Vienna 19
Tashkent 18
Brescia 17
Hangzhou 17
San Francisco 17
Ankara 16
Assago 16
Buffalo 16
Cesano Boscone 16
Da Nang 16
Florence 16
Princeton 16
Shenzhen 16
The Dalles 16
Haiphong 15
Lawrence 15
Biên Hòa 14
Falkenstein 13
Mumbai 13
Quito 13
Sydney 13
Tianjin 13
Abu Dhabi 12
Querétaro 12
Amman 11
City of London 11
Memphis 11
Turin 11
Bang Kruai 10
Charlotte 10
Curitiba 10
Dalian 10
Fortaleza 10
Jeddah 10
Riyadh 10
St Louis 10
Bari 9
Campinas 9
Lahore 9
Pisa 9
Rabat 9
Salvador 9
Aracaju 8
Boston 8
Brasília 8
Dhaka 8
Totale 7.928
Nome #
Contrast-Enhanced Mammography versus Breast Magnetic Resonance Imaging: A Systematic Review and Meta-Analysis 190
[68Ga]Ga-PSMA and [68Ga]Ga-RM2 PET/MRI vs. Histopathological Images in Prostate Cancer: A New Workflow for Spatial Co-Registration 184
Early regression index (ERI) on MR images as response predictor in esophageal cancer treated with neoadjuvant chemo-radiotherapy: interim analysis of the prospective ESCAPE trial 163
EANM/EARL FDG-PET/CT accreditation - summary results from the first 200 accredited imaging systems 146
A Multimodal Protocol Combining 99mTc-Tilmanocept with Indocyanine Green Fluorescence Lympho-Angiography for Sentinel Lymph Node Biopsy in Early-Stage Oral Cancer: A Case Series. 146
[18F]FDG-PET/CT Texture Analysis in “Hot” Thyroid Nodules: Results of the validation Cohort 143
Deep learning in Nuclear Medicine—focus on CNN-based approaches for PET/CT and PET/MR: where do we stand? 126
null 126
Allogeneic Stem Cell Transplantation (Allo-SCT) after Treatment with Programmed Cell Death-1 (PD-1) Checkpoint Inhibitors for Relapsed/Refractory Classic Hodgkin Lymphoma (R/R cHL) Is Associated with an Unprecedented Low Relapse Rate 124
The Role of Prostate-specific Membrane Antigen Positron Emission Tomography for Assessment of Local Recurrence and Distant Metastases in Patients with Biochemical Recurrence of Prostate Cancer After Definitive Treatment: A Systematic Review and Meta-analysis 121
Use of 18F-fluoro-2-deoxy-d-glucose (18F-FDG) PET/CT for lymph node assessment before radical cystectomy in bladder cancer patients 118
Prognostic Value of Metabolic Imaging Data of 11C-choline PET/CT in Patients Undergoing Hepatectomy for Hepatocellular Carcinoma 117
[F-18]FDG PET/CT in non-union: improving the diagnostic performances by using both PET and CT criteria 117
[18F]FDG PET/CT in Large Vessel Vasculitis: The Impact of Expertise and Confounders on Image Analysis 115
Preoperative assessment of lymph nodal metastases with [68Ga]Ga-DOTATOC PET radiomics for improved surgical planning in well-differentiated pancreatic neuroendocrine tumours 115
Random forest analysis to predict Disease-Free Survival using FDG-PET and CT in Lung Cancer 114
Predictors of PSMA PET Positivity: Analysis in a Selected Cohort of Biochemical Recurrence Prostate Cancer Patients after Radical Prostatectomy 113
Challenging the significance of SUV-based parameters in a large-scale retrospective study on lung lesions 113
Diagnostic accuracy of fully hybrid [68Ga]Ga-PSMA-11 PET/MRI and [68Ga]Ga-RM2 PET/MRI in patients with biochemically recurrent prostate cancer: a prospective single-center phase II clinical trial 112
Cutting back on overdiagnosis – Occam’s Razor and unspecific bone uptakes in PSMA PET 111
Malignant pleural effusion (MPE) characterized with 11C-Methionine PET/CT before and after talc pleurodesis: interim evaluation of a prospective clinical trial 111
Which Patients with Prostate Cancer and Lymph Node Uptake at Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography/Computerized Tomography Scan Are at a Higher Risk of Prostate-specific Antigen Persistence After Radical Prostatectomy? Identifying Indicators of Systemic Disease by Integrating Clinical, Magnetic Resonance Imaging, and Functional Imaging Parameters 110
Match Point: Nuclear Medicine Imaging for Recurrent Thyroid Cancer in TENIS Syndrome—Systematic Review and Meta-Analysis 110
Time for action: actinium-225 PSMA-targeted alpha therapy for metastatic prostate cancer – a systematic review and meta-analysis 110
Are three weeks hypofractionated radiation therapy (HFRT) comparable to six weeks for newly diagnosed glioblastoma patients? Results of a phase II study 109
Defining the optimal target-to-background ratio to identify positive lymph nodes in prostate cancer patients undergoing robot-assisted [99mTc]Tc-PSMA radioguided surgery: updated results and ad interim analyses of a prospective phase II study 109
PSMA PET in brain metastases: navigating diagnostic challenges– a thorough exploration 108
Single-Center Retrospective Study Comparing Double Vein Embolization via a Trans-Jugular Approach with Liver Venous Deprivation via a Trans-Hepatic Approach 107
Imaging in Gastroparesis: Exploring Innovative Diagnostic Approaches, Symptoms, and Treatment 105
A Comprehensive Systematic Review and Meta-analysis of the Role of Prostate-specific Membrane Antigen Positron Emission Tomography for Prostate Cancer Diagnosis and Primary Staging before Definitive Treatment 105
Systematic Review and Metanalysis on the Role of Prostate-Specific Membrane Antigen Positron Emission Tomography/Magnetic Resonance Imaging for Intraprostatic Tumour Assessment 104
Senna intoxication as a cause of extrapontine myelinolysis mimicking rapidly progressive dementia: a case description 102
A virtual biopsy of liver parenchyma to predict the outcome of liver resection 101
Advanced Imaging Supports the Mechanistic Role of Autoimmunity and Plaque Rupture in COVID-19 Heart Involvement 100
ALBI grade for outcome prediction in patients affected by hepatocellular carcinoma treated with transarterial radioembolization 100
Ability of FDG PET and CT radiomics features to differentiate between primary and metastatic lung lesions 100
Virtual Biopsy for Diagnosis of Chemotherapy-Associated Liver Injuries and Steatohepatitis: A Combined Radiomic and Clinical Model in Patients with Colorectal Liver Metastases 98
48P The relationship among bowel FDG-PET uptake, pathological complete response, and the influence of eating and exercise habits in breast cancer patients undergoing neoadjuvant chemotherapy 97
External Validation of Nomograms for the Identification of Pelvic Nodal Dissection Candidates Among Prostate Cancer Patients with Negative Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography 97
Radioembolization for Hepatocellular Carcinoma: a Comparison on Dual-phase Cone-beam CT, Contrast-enhanced CT (CECT) and 99mTc-macroaggregated albumin-SPECT/CT in predicting final distribution volumes and dosimetry of the post-embolization 90Y PET/CT 96
Baseline circulating tumour DNA and interim PET predict response in relapsed/refractory classical Hodgkin lymphoma 96
Smaller is better? Compact vs. Conventional gamma camera for sentinel lymph node localization in patients with breast cancer 94
Computed tomography based radiomic signature as predictive of survival and local control after stereotactic body radiation therapy in pancreatic carcinoma 93
The diagnostic and prognostic value of tau-PET in amnestic MCI with different FDG-PET subtypes 93
Computed tomography (CT)-derived radiomic features differentiate prevascular mediastinum masses as thymic neoplasms versus lymphomas 93
Absorbed dose from daily routine practice in an 18F-FDG producing radiopharmacy 93
Imaging-Based Prediction of Molecular Therapy Targets in NSCLC by Radiogenomics and AI Approaches: A Systematic Review 91
A reflection on journal rankings 91
The Challenge of External Generalisability: Insights from the Bicentric Validation of a [68Ga]Ga-PSMA-11 PET Based Radiomics Signature for Primary Prostate Cancer Characterisation Using Histopathology as Reference 90
[18F]FDG PET/MRI vs sentinel node biopsy for axillary staging of early breast cancer patients. A prospective single-arm trial 88
Baseline FDG-PET/CT Radiomics to Predict Outcome in Lung Cancer Patients Treated with Surgery 86
Advancing EJNMMI: continuing success and next developments 86
State-of-the-art of FAPI-PET imaging: a systematic review and meta-analysis 86
Baseline Radiomic CT Features Differentiate Mediastinal Masses As Thymic Neoplasms Or Lymphomas 84
The five “W”s and “How” of Targeted Alpha Therapy: Why? Who? What? Where? When? and How? 84
18F-FDG PET and CT scan in the pre-operative evaluation of colorectal liver metastases treated with chemotherapy 84
Mapping brain metabolism, connectivity and neurotransmitters topography in early and late onset dementia with lewy bodies 83
68GA-PSMA PET/CT FOR PRIMARY DIAGNOSIS OF PROSTATE CANCER IN MEN WITH CONTRAINDICATIONS TO OR NEGATIVE MRI: A PROSPECTIVE OBSERVATIONAL STUDY 82
Correction: Radioembolization for Hepatocellular Carcinoma: a Comparison on Dual-phase Cone-beam CT, Contrast-enhanced CT (CECT) and 99mTc-macroaggregated albumin-SPECT/CT in predicting final distribution volumes and dosimetry of the post-embolization 90Y PET/CT 79
I-131/I-123-Metaiodobenzylguanidine (mIBG) scintigraphy: procedure guidelines for tumour imaging 78
Prevention of Orbitopathy by Oral or Intravenous Steroid Prophylaxis in Short Duration Graves' Disease Patients Undergoing Radioiodine Ablation: A Prospective Randomized Control Trial Study 77
Biological characterization of renal masses using immuno-PET 75
Towards clinical application of image mining: a systematic review on artificial intelligence and radiomics 75
New Mitral Regurgitation Unveiling Infective Endocarditis in an Adolescent With Mitral Valve Prolapse 74
The potential role of osteoporosis in unspecific [18F]PSMA-1007 bone uptake 72
Application of Convolutional Neural Networks is promising in the definition of T-stage in lung cancer 72
Imaging of neuroendocrine tumours with gamma-emitting radiopharmaceuticals 71
Perceived risk and decision-making: navigating uncertainty in clinical practice 71
Liver metastases from prostate cancer at 11C-Choline PET/CT: a multicenter, retrospective analysis 71
Role of 11C Methionine Positron Emission Tomography (11CMETPET) for Surgery and Radiation Therapy Planning in Newly Diagnosed Glioblastoma Patients Enrolled into a Phase II Clinical Study 71
Identifying critical steps towards improved access to innovation in cancer care: a European CanCer Organisation position paper 70
Convolutional Neural Networks Promising in Lung Cancer T-Parameter Assessment on Baseline FDG-PET/CT 70
PET/CT-based radiomics of mass-forming intrahepatic cholangiocarcinoma improves prediction of pathology data and survival 70
Individual cerebral metabolic deficits in Alzheimer's disease and amnestic mild cognitive impairment: an FDG PET study 70
C-11-Methionine uptake in secondary brain epilepsy 70
Radiomics of Liver Metastases: A Systematic Review 70
Ga-68-PSMA Positron Emission Tomography/Computerized Tomography for Primary Diagnosis of Prostate Cancer in Men with Contraindications to or Negative Multiparametric Magnetic Resonance Imaging: A Prospective Observational Study 68
Intrahepatic cholangiocellular carcinoma with radiological enhancement patterns mimicking hepatocellular carcinoma 68
The complementary role of PSMA expression and [18F]FDG PET/CT in predicting thyroid cancer outcome: from black and white to shades of gray, in the era of precision oncology 68
Functional Investigation of the Tumoural Heterogeneity of Intrahepatic Cholangiocarcinoma by In Vivo PET-CT Navigation: A Proof-of-Concept Study 67
Vasculitis changes in COVID-19 survivors with persistent symptoms: an [18F]FDG-PET/CT study 66
The Role of PET Imaging in the Differential Diagnosis between Radiation Necrosis and Recurrent Disease in Irradiated Adult-Type Diffuse Gliomas: A Systematic Review 65
Radiomics and gene expression profile to characterise the disease and predict outcome in patients with lung cancer 65
Ga-68-PSMA PET/CT for primary diagnosis of prostate cancer in men with contraindications to or negative mpMRI 65
Enhancing NSCLC Histological Subtype Classification: A Federated Learning Approach Using Triplet Loss 65
PSMA guided approach for bIoCHEmical relapse after prostatectomy- (PSICHE) trial (NCT05022914). Detection rate and treatment decision after 68Ga-PSMA PET/CT within a prospective study 65
The future of transpathology 64
Short-term health-related quality of life, physical function and psychological consequences of severe COVID-19 63
Radioguided Surgery for Prostate Cancer 62
Long COVID hallmarks on [18F]FDG-PET/CT: a case-control study 62
Radiomics of Intrahepatic Cholangiocarcinoma and Peritumoral Tissue Predicts Postoperative Survival: Development of a CT-Based Clinical-Radiomic Model 62
Advances in Diagnostic Imaging 62
Myocardial involvement in systemic sclerosis 62
Hodgkin lymphoma and imaging in the era of anti-PD-1/PD-L1 therapy 61
Minimally-invasive treatments for benign thyroid nodules: a Delphi-based consensus statement from the Italian minimally-invasive treatments of the thyroid (MITT) group 61
Internal Guidelines for Reducing Lymph Node Contour Variability in Total Marrow and Lymph Node Irradiation 61
Hybrid PET/MRI in Infection and Inflammation: An Update About the Latest Available Literature Evidence 60
EANM/EARL FDG-PET/CT accreditation - summary results from the first 150 accredited imaging sites 60
Extended nodal radiotherapy for prostate cancer relapse guided with [11C]-choline PET/CT: ten-year results in patients enrolled in a prospective trial 60
Complete remission of follicular lymphoma after SARS-CoV-2 infection: from the "flare phenomenon" to the "abscopal effect" 60
Totale 9.118
Categoria #
all - tutte 73.322
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 73.322


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20225 0 0 0 5 0 0 0 0 0 0 0 0
2022/2023466 34 16 7 0 0 5 2 6 8 52 324 12
2023/20241.042 16 78 110 70 81 164 63 119 61 76 54 150
2024/20253.042 296 93 38 94 157 297 347 269 522 431 252 246
2025/202611.252 798 751 668 1.368 954 410 1.257 827 2.898 754 551 16
Totale 15.821